Human umbilical cord blood (UCB) represents a valuable source of hematopoietic stem
cells, particularly for patients lacking a matching donor. UCB provides practical advantages …

Human umbilical cord blood (UCB) represents a unique resource for hematopoietic stem
cell transplantation for children and patients lacking suitable donors. UCB harbors a diverse …

Umbilical cord blood (UCB) is a source of primitive hematopoietic stem (HSC) and
progenitor cells, that served as an alternative to bone marrow (BM) for effective …

Cord blood stem cells (CB-SCs) have shown impressive immunological and regenerative
capabilities. In this review, we intend to review the state-of-the-art knowledge on CB-SCs …

Although used mainly for transplantation of hematopoietic stem cells in the treatment of
blood disorders, umbilical cord blood (UCB)-based therapies are now being used …

While cord blood (CB) is primarily utilized in allogeneic hematopoietic cell transplantation
(HCT), the development of novel cell therapy products from CB is a growing and developing …

This review focuses on the therapeutic features of umbilical cord blood (UCB) cells as a
source for allogeneic hematopoietic stem cell transplantation (aHSCT) in adult and child …

Since the first cord blood transplantation in 1988, umbilical cord blood has become an
important option as a source of cells for hematopoietic transplantation. Beyond its role in …

Umbilical cord blood (UCB) is a primitive and abundant source of mesenchymal stem cells
(MSCs). UCB-derived MSCs have a broad and efficient therapeutic capacity to treat various …

Because of its easier accessibility and less severe graft-versus-host disease, umbilical cord
blood (UCB) has been increasingly used as an alternative to bone marrow for hematopoietic …